Jesús
Fortun Abete
Profesor/a Asociado/a en CC. de la Salud
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (41)
2024
-
Corrigendum to “Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients” [International Journal of Infectious Diseases 144 (2024) 107070] (International Journal of Infectious Diseases (2024) 144, (S1201971224001413), (10.1016/j.ijid.2024.107070))
International Journal of Infectious Diseases
-
Safety and effectiveness of isavuconazole in real-life non-neutropenic patients
International Journal of Infectious Diseases, Vol. 144
2022
2021
-
Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study)
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 8
-
Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipients
American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2709-2718
2020
-
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4
-
Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients
Frontiers in Immunology, Vol. 11
-
Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus
Transplantation Reviews, Vol. 34, Núm. 2
2018
-
A 5-year prospective multicenter evaluation of influenza infection in transplant recipients
Clinical Infectious Diseases, Vol. 67, Núm. 9, pp. 1322-1329
2017
-
Epidemiology and prognosis of candidaemia in elderly patients
Mycoses, Vol. 60, Núm. 12, pp. 808-817
-
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia
Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8
-
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11
-
Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: Results of TRANSGRIPE 1-2, a randomized controlled clinical trial
Clinical Infectious Diseases, Vol. 64, Núm. 7, pp. 829-838
2016
-
Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort
Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8
2015
-
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains
Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9
-
Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance
Journal of Infection, Vol. 71, Núm. 3, pp. 385-394
-
Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: RESULTS from a population-based surveillance in Spain
Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 491.e1-491.e10
-
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe
Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1040.e11-1040.e18
2014
-
Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation
Transplant Infectious Disease, Vol. 16, Núm. 4, pp. 532-538
-
EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations
Revista Iberoamericana de Micologia, Vol. 31, Núm. 3, pp. 157-175